Illumina(ILMN)

Search documents
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2024
Prnewswire· 2024-11-04 21:05
Core Illumina revenue of $1.1 billion for Q3 2024, down 2% from Q3 2023 and on a constant currency basis Core Illumina GAAP operating margin of 68.6% and non-GAAP operating margin of 22.6% for Q3 2024 Core Illumina GAAP diluted EPS of $4.03 and non-GAAP diluted EPS of $1.14 for Q3 2024 Lowered fiscal year 2024 Core Illumina revenue guidance to decline ~3% from fiscal year 2023; expect Q4 2024 Core Illumina revenue of approximately $1.07 billion Raised fiscal year 2024 Core Illumina non-GAAP operating margi ...
Illumina to preview newest innovations in NGS and multiomic technologies at the American Society of Human Genetics Annual Meeting
Prnewswire· 2024-10-31 13:15
New, groundbreaking technology delivers Illumina's most comprehensive genome yet; early results from Broad Clinical Labs demonstrate a highly simplified workflow, ultra-long phasing, high-resolution insights into complex genomic variation, and enhanced long-range information Illumina and customers will also showcase new details on complete proteomics solution and latest data on Fluent single-cell technologySAN DIEGO, Oct. 31, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequ ...
What Analyst Projections for Key Metrics Reveal About Illumina (ILMN) Q3 Earnings
ZACKS· 2024-10-30 14:20
Wall Street analysts forecast that Illumina (ILMN) will report quarterly earnings of $0.87 per share in its upcoming release, pointing to a year-over-year increase of 163.6%. It is anticipated that revenues will amount to $1.08 billion, exhibiting a decline of 3.6% compared to the year-ago quarter. The consensus EPS estimate for the quarter has undergone an upward revision of 0.8% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed th ...
Illumina's Q3 Earnings Coming Up: Time to Buy, Sell or Hold the Stock?
ZACKS· 2024-10-24 17:02
Sequencing giant Illumina Inc. (ILMN) is set to release third-quarter 2024 results on Nov. 4 after the closing bell.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.According to the Zacks Consensus Estimate, the company’s third-quarter earnings are expected to surge by 163.6% to 87 cents per share. The estimate has remained unchanged in the past 60 days. However, the Zacks Consensus Estimate for revenues currently stands at $1.08 billion, a 3.7% decrease compared to the last year.Ima ...
ILMN Stock Trading Near 52-Week High: Should You Buy, Sell or Hold?
ZACKS· 2024-10-18 14:05
Shares of Illumina (ILMN) have been showcasing impressive market performance, reaching a new 52-week-high of $151.04 during Tuesday’s trading session. The stock finished at $143.52 yesterday, just 5.2% short of its peak.The surge comes soon after the company's announcement on Oct. 9 of the launch of its MiSeq i100 Series of sequencing systems, an upgrade to the original benchtop MiSeq System from 2011. The new MiSeq i100 and MiSeq i100 Plus Systems offer major technological enhancements, including a reducti ...
Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers
Prnewswire· 2024-10-09 16:10
The two new benchtop instruments, MiSeq i100 and MiSeq i100 Plus Systems, will empower customers to unlock powerful insights through an affordable, comprehensive solution that is simple to understand and use, even for those with limited NGS expertise. Room-temperature storage and shipping enable labs to sequence on demand, with no delays for thaw time, and same-day sample-to-analysis."Our customers told us they need a faster, smaller, and easy-to-use instrument, and that's what we're delivering with the MiS ...
Here's Why Illumina (ILMN) is a Strong Momentum Stock
ZACKS· 2024-10-08 14:55
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium includes access to the Zacks Style Scores as well.What are the Zacks Style Scores?The Zac ...
Illumina to Announce Third Quarter 2024 Financial Results on Monday, November 4, 2024
Prnewswire· 2024-10-07 20:05
SAN DIEGO, Oct. 7, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the third quarter 2024 following the close of market on Monday, November 4, 2024. On the same day, at 1:30 pm Pacific Time (4:30 pm Eastern Time) Jacob Thaysen, PhD, Chief Executive Officer, and Ankur Dhingra, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results. Conference Call Details The confe ...
Revisiting Illumina
Seeking Alpha· 2024-10-07 04:36
One year ago, I wrote a bullish article on Illumina (NASDAQ: ILMN ), which I encourage readers to review as a primer for this piece. ILMN has provided a total return of 25% (including a slight benefit of the GRAIL (Edward Schneider is a managing director of Quan Management LLC. Mr. Schneider has over 30 years of investment experience, including 25 years managing technology funds in both quoted equities and venture capital. Mr. Schneider holds a CFA designation, an MBA from Thunderbird and a BA from Emory Un ...
GRAIL: Post-Spinoff, Illumina Maintains Control And Incentive To Support Success
Seeking Alpha· 2024-09-24 16:41
In June 2024, GRAIL, Inc. (NASDAQ: GRAL ) was spun-off from Illumina, Inc. ( ILMN ), which had initially acquired GRAIL as recently as 2021. After struggling to defend the merger with regulatory agencies in theI'm Construction Manager for one of America's largest retailers by day, and a stock analyst by night (usually early morning). As a self-taught investor, everything I know about investing came from reading books. Mainly Benjamin Graham, Joel Greenblatt, and Tobias Carlisle, but also countless others.. ...